UNSPSC 51191605: Sterile water for injection

This classification denotes an electrolyte-active substance, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 059QF0KO0R. European Medicines Agency schedules Water in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15717MIG. Water generally arises in the molecular formula H2O. The term 'water' is a United States Homeopathic Pharmacopoeia Name designation. SMILES: O.

UNSPSC 51191605 Sterile water for injection is a Commodity code that encompasses chemical supplies for water treatment and pharmaceutical manufacturing operations across state and local government facilities. The recent solicitations posted under this code reflect two distinct procurement streams: municipal water treatment chemicals for pollution control facilities and multi-source pharmaceutical and over-the-counter products distributed through state and local health and human services networks. State and local governments source these materials through a mix of direct municipal bids and cooperative purchasing arrangements that aggregate demand across multiple jurisdictions and facility types, including water pollution control plants, health departments, and hospital networks.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026; awarded vendors were to be identified by May 15, 2026 with contracts effective July 1, 2026. The City of Meriden, Connecticut posted an IFB under solicitation B027-15 on July 8, 2026 for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026. Geographic activity spans Minnesota, Connecticut, and Oregon (through MMCAP participation), with the cooperative purchasing vehicle dominating the pharmaceutical procurement stream while municipal water authorities manage chemical supply independently. The MMCAP procurement evaluated vendors on price competitiveness (75 percent weight), fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and administrative fee structure (5 percent), requiring manufacturers to maintain relationships with AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, or Morris & Dickson Co., LLC and to demonstrate cGMP compliance and Drug Supply Chain Security Act certification.